Premium
Expression of leucocyte adhesion molecules at the human blood‐brain barrier (BBB)
Author(s) -
Rössler K.,
Neuchrist C.,
Kitz K.,
Scheiner O.,
Kraft D.,
Lassmann H.
Publication year - 1992
Publication title -
journal of neuroscience research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.72
H-Index - 160
eISSN - 1097-4547
pISSN - 0360-4012
DOI - 10.1002/jnr.490310219
Subject(s) - parenchyma , cell adhesion molecule , blood–brain barrier , pathology , endothelium , immunocytochemistry , neuropil , intercellular adhesion molecule 1 , inflammation , cd44 , biology , microglia , adhesion , icam 1 , microbiology and biotechnology , central nervous system , chemistry , immunology , medicine , neuroscience , in vitro , biochemistry , endocrinology , organic chemistry
The expression of leucocyte adhesion molecules was studied on cerebral endothelia by immunocytochemistry. In peritumoral “normal” brain tissue we found low endothelial expression of 1CAMI, LFA3, CD44, and CD9, whereas VLA1 was present on vessels in high incidence and density. LFAl, CD2, and CR3 were found on intraluminal and parenchymal leucocytes, but were absent on brain vessels. In brain tumors and inflammatory brain lesions, we observed an up‐regulation of endothelial ICAM1 and LFA3 expression, whereas other adhesion molecules on endothelial cells remained unchanged. Within the brain parenchyma, ICAM1 and LFA3 were found on astrocytes and tumor cells; on the contrary, LFA1 was expressed on microglial cells similar to CR3. CD44 and CD9 showed a diffuse neuropil expression in normal and tumoral tissue, whereas VLA1 was not expressed on any parenchymal cells. Our data show that multiple different adhesion molecules are present on blood‐brain barrier endothelium (BBB) under normal conditions and some adhesion molecules are up‐regulated in brain tumors and under inflammatory conditions. The presence of adhesion molecules in the vessel walls as well as on parenchymal cells like astrocytes and microglia may guide inflammatory cells into and through the brain in the course of immune surveillance and inflammation.